Published in
American Society of Hematology, Blood, Supplement 1(140), p. 9046-9047, 2022
DOI: 10.1182/blood-2022-157606
Links
Tools
Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine and Venetoclax in Patients with Acute Myeloid Leukemia (ASPEN-05): Results from Phase 1a Dose Escalation Part
Journal article published in 2022 by
Guillermo Garcia-Manero,
Amanda Przespolewski,
Yasmin Abaza,
Michael Byrne,
Abraham P. Fong,
Feng Jin,
Alison J. Forgie,
Athanasios C. Tsiatis,
Shanhong Guan,
Harry P. Erba
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 